Replies to post #656370 on NorthWest Biotherapeutics Inc (NWBO)

[vator]

You are a shareholder. Owner of the company. Not knowing what Advent will be paid for producing commercial product has impact on any investment decision with this company.

You own and helped pay for the buildout of a manufacturing facility and for work performed by Advent. Not knowing a return is willful blindness. At this point management should be providing targets for revenue for the company. Pessimistic and optimistic. Long past due for any investor. There is a reason only the creepiest of analysts (if you want to call him an analyst) follow the company. Quarterly calls and well thought out targets bring accredited analysts.

The reason some people you want to keep in the dark are here posting because the company keeps shareholders in the dark. Easy to make a negative narrative with an information vacuum.

[HappyLibrarian]

Where is the Specials revenue?

Shareholders have a right to know especially in light of the previous (perfectly legal) but less than advantageous Cognate deal.

If there is no revenue in late 2023 why not?

This concerns one of our few near term sources of revenue when almost every dollar spent comes out of our equity ‘right before the end.’

Only a (hopefully unpaid and uncoordinated) management denies our moral if not legal right to know (laws are written by lobbyists so we have few legal rights of course).

[manibiotech]

If you take public money , it’s your ethical duty to explain the public where that money is being used . That’s the concept of public companies , that’s why public companies have quarterly calls .
If you want to keep everything secret , stay private
It maybe very hard concept for you to understand

[vator]

On my second thought about your post - If management cannot stand the scrutiny when transparent by message board posters, then we really are in trouble. Time for this company to grow up!